IP Library Granted Patent US 6,852,725
Granted Patent B1
US 6,852,725 · App. 09/719,457 · Granted Feb 8, 2005

Imidazolyl derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,852,725
App. No.
09/719,457
Granted
Feb 8, 2005
Kind
B1
Abstract

The present invention is directed to imidazolyl derivatives of the formula: where the substituents are defined in the specification, or a pharmaceutically acceptable salt thereof. The derivatives bind selectively to the somatostatin subtype receptors and elicit either an agonist or antagonist effect from the somatostatin subtype receptors. The derivatives are useful for treating a variety of diseases including acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, VIPoma, nesidoblastosis, hyperinsulinism, gastrinoma, Zollinger-Ellison Syndrome, diarrhea, AIDS related diarrhea, chemotherapy related diarrhea, scleroderma, Irritable Bowel Syndrome, pancreatitis, small bowel obstruction, gastroesophageal reflux, duodenogastric reflux, Cushing's Syndrome, gonadotropinoma, hyperparathyroidism, Graves' Disease, diabetic neuropathy, Paget's disease, polycystic ovary disease, cancer, cancer cachexia, hypotension, postprandial hypotension, panic attacks, GH secreting adenomas or TSH secreting adenomas.

Claims (11)

1. A compound of the formula

the racemic-diastereomeric mixtures and optical isomers of said compound or a pharmaceutically acceptable salt thereof,

wherein

R 3 is —(CH 2 ) m —E—(CH 2 ) m —Z 2 ;

E is O, S, —C(O)—, —C(O)—O—, —NH—C(O)—O—, —N—(C 1 -C 6 )alkyl-C(O)—O— or a bond;

Z 2 is H, (C 1 -C 12 )alkyl, amino, (C 1 -C 12 )alkylamino, N,N-di-(C 1 -C 12 )alkylamino, (C 1 -C 12 )alkylguanidino, or an unsubstituted or substituted moiety selected from the group consisting of phenyl, indolyl, imidazolyl, thiophene, benzothiophene, pyridinyl and naphthyl;

Z 3 is

X 1 is —(CH 2 ) 2 —N(CH 3 ) 2 and X 2 is benzyl; or

X 1 and X 2 are taken together with the nitrogen atom to which they are attached, to form

2. A compound of the formula

3. A compound of the formula

Assignments (4)
CHANGE OF NAME Recorded Feb 11, 2009
From: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
To: IPSEN PHARMA S.A.S.
Reel/Frame 022240/0332 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 24, 2001
From: BIOMEASURE, INCORPORATED
To: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES, S.A.S.
Reel/Frame 011891/0792 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2001
From: THURIEAU, CHRISTOPHE ALAIN; POITOUT, LYDIE FRANCINE; GALCERA, MARIE-ODILE; MOINET, CHRISTOPHE PHILIPPE
To: SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFQUES S.A.
Reel/Frame 011902/0773 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2001
From: MORGAN, BARRY A.; GORDON, THOMAS D.
To: BIOMEASURE, INCORPORATED
Reel/Frame 011844/0198 →